Cargando…
Discovery and validation of a colorectal cancer classifier in a new blood test with improved performance for high-risk subjects
BACKGROUND: The aim was to improve upon an existing blood-based colorectal cancer (CRC) test directed to high-risk symptomatic patients, by developing a new CRC classifier to be used with a new test embodiment. The new test uses a robust assay format—electrochemiluminescence immunoassays—to quantify...
Autores principales: | Croner, Lisa J., Dillon, Roslyn, Kao, Athit, Kairs, Stefanie N., Benz, Ryan, Christensen, Ib J., Nielsen, Hans J., Blume, John E., Wilcox, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526294/ https://www.ncbi.nlm.nih.gov/pubmed/28769740 http://dx.doi.org/10.1186/s12014-017-9163-z |
Ejemplares similares
-
A Plasma-Based Protein Marker Panel for Colorectal Cancer Detection Identified by Multiplex Targeted Mass Spectrometry
por: Jones, Jeffrey J., et al.
Publicado: (2016) -
Screening for colorectal cancer: possible improvements by risk assessment evaluation?
por: Nielsen, Hans J, et al.
Publicado: (2011) -
Early Detection and Recurrence of Colorectal Adenomas by Combination of Eight Cancer-Associated Biomarkers in Plasma
por: Rasmussen, Louise, et al.
Publicado: (2020) -
Cathepsin X in serum from patients with colorectal cancer: relation to prognosis
por: Vizin, Tjasa, et al.
Publicado: (2012) -
Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer
por: Rasmussen, Louise, et al.
Publicado: (2017)